medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2013, Number 4

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2013; 11 (4)

Genital skin diseases

Peña RAG, Díaz GJM, Domínguez CJ, Domínguez SL

Language: Spanish
References: 70
Page: 288-302
PDF size: 405.89 Kb.


ABSTRACT

Genitalia are susceptible to a variety of dermatoses both originating in the area or secondary to systemic disorders. As these entities are relatively common, it is fundamental to be aware of their clinical features, diagnostic approach and treatment. This is a review of the most common genital dermatological disease and includes a brief analysis on the etiology, diagnosis and management of each entity.


REFERENCES

  1. Agrawal SK, Bhattacharya SN, Singh N. “Pearly penile papules: a review”. Int J Dermatol 2004: 43; 199-201.

  2. Hogewoning CJ, Bleeker MC, van den Brule AJ, et al. “Pearly penile papules: Still no reason for uneasiness”. J Am Acad Dermatol 2003; 49: 50-54.

  3. Chih-Chieh C., Hsien-Ching C. “Vestibular Papillomatosis”. N Engl J Med 2008; 358: 1495.

  4. Alikhan A, Felsten LM, Daly M, et al. “Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up”. J Am Acad Dermatol 2011; 65: 473-491.

  5. Zhang Z, Xu SX, Zhang FY, Yin XY, Yang S, Xiao FL, et al. “The analysis of genetics and associated autoimmune diseases in Chinese vitiligo patients”. Arch Dermatol Res 2009; 301: 167-173.

  6. Bolognia JL , Jorizzo JL, Schaffer JV. Dermatology. 3a ed, EUA, Elsevier, 2012.

  7. Taieb A, Alomar A, Bohm M, et al. “Guidelines for the management of vitiligo: the European Dermatology Forum consensus”. Br J Dermatol 2013; 168: 5-19.

  8. Christophers E: “Psoriasis-epidemiology and clinical spectrum”. Clin Exp Dermatol 2001; 26: 314-320.

  9. Swanbeck G, Inerot A, Martinsson T, et al. “Age at onset and different types of psoriasis”. Br J Dermatol 1995; 133: 768-773.

  10. Schmitt-Egenolf M, Eiermann TH, Boehncke WH, et al. “Familial juvenile onset psoriasis is associated with the human leukocyte antigen (HLA) class I side of the extended haplotype Cw6-B57-DRB1*0701- DQA1*0201-DQB1*0303: a population- and family-based study”. J Invest Dermatol 1996; 106: 711-714.

  11. Meeuwis KA, de Hullu JA, van de Nieuwenhof HP, et al. “Quality of life and sexual health in patients with genital psoriasis”. Br J Dermatol. 2011; 164: 1247-1255.

  12. Quan MB, Ruben BS. “Pustular psoriasis limited to the penis”. Int J Dermatol 1996; 35: 202-204.

  13. van Dijk F, Thio HB, Neumann HAM. “Non-Oncological and Non- Infectious Diseases of the Penis (Penile Lesions)”. EAU–EBU Upt. 2006; 4: 13-19.

  14. Menter CA, Korman NJ, Elmets CA, “Guidelines of care for the management of psoriasis and psoriatic arthritis”. J Am Acad Dermatol 2011; 65: 137-174.

  15. Meeuwis K, Hullu J, Massuger L, Keerkhof P, Rossum M. “Genital psoriasis: a systematic literature review on this hidden skin disease”. Acta Derm Venereol. 2011; 91: 5-11.

  16. F. van Dijk, Neumann T. “Non-Oncological and Non-Infectious Diseases of the Penis (Penile Lesions)”. EAU-EBU update series 4 (2006): 13-19.

  17. Hoshi A, Usui Y, Terachi T. “Penile Carcinoma Originating From Lichen Planus on Glans Penis”. Urology 2008 May; 71(5): 816-817.

  18. Petropoulou H. “Effective treatment of erosive lichen planus with thalidomide and topical tacrolimus”. Int J Dermatol. 2006 Oct; 45(10): 1244-1245.

  19. Porter WM, Dinneenà M, Hawkins DA, Bunker CB. “Erosive penile lichen planus responding to circumcision”. J Eur Acad Dermatol Venereol 2001 May; 15(3): 266-268.

  20. Lewis FM. “Vulval lichen planus”. Br J Dermatol 1998; 138: 569-575.

  21. Clouston D, Hall A, Lawrentschuk N. “Penile lichen sclerosus (balanitis xeroticaobliterans)”. BJUI 2011; 108(Supp 2): 14-19.

  22. Lukowsky A, Muche JM, Sterry W, et al. “Detection of expanded T cell clones in skin biopsy samples of patients with lichen sclerosus et atrophicus by T cell receptor-gamma polymerase chain reaction assays”. J Invest Dermatol 2000; 115: 254-259.

  23. Meyrick Thomas RH, Ridley CM, McGibbon DH, et al. “Lichen sclerosus et atrophicus and autoimmunityea study of 350 women”. Br J Dermatol 1988; 118: 41-46.

  24. Harrington CI, Dunsmore IR. “An investigation into the incidence of auto-immune disorders in patients with lichen sclerosus and atrophicus”. Br J Dermatol 1981; 104: 563-566.

  25. Bunker CB. “Topics in penile dermatology”. Clin Exp Dermatol 2001; 26: 469-479.

  26. Ching-Chi Chi, Kirtschig G, Baldo M, et al. “Systematic review and metaanalysis of randomized controlled trials on topical interventions for genital lichen sclerosus”. J Am Acad Dermatol 2012; 67: 305-312.

  27. Edmonds EVJ, Hunt S, Hawkins D, et al. “Clinical parameters in male genital lichen sclerosus: a case series of 329 patients”. JEADV 2012; 26: 730-737.

  28. Fistarol S, Itin P. “Diagnosis and Treatment of Lichen Sclerosus An Update”. Am J Clin Dermatol (2013); 14: 27-47.

  29. Yoganathan S, Bohl TG, Mason G. “Plasma cell balanitis and vulvitis (of Zoon). A study of 10 cases”. J Reprod Med 1994; 39: 939-944.

  30. Bunker CB. “Topics in penile dermatology”. Clin Exp Dermatol. 2001; 26: 469-479.

  31. English JC, MC, Laws RA, Keough GC, Wilde JL, Foley JP, Elston DM. “Dermatoses of the glans penis and prepuce”. J Am Acad Dermatol 1997; 37: 1-24.

  32. Sonnex C. “Genital allergy”. Sex Transm Infect 2004; 80:4-7.

  33. Plaza JA, James WD. “Erythema Multiforme”. http://emedicine.medscape. com/article/1122915-overview.

  34. Guerra Tapia A. “Patologia Genital Masculina ampollosa no venérea”. Monografías de Dermatología 2012; 25: 103-109.

  35. Sekula P, Dunant A, Mockenhaupt M, Naldi L, Bouwes Bavinck JN, Halevy S, Kardaun S, Sidoroff A, Liss Y, Schumacher M, Roujeau JC. “Comprehensive Survival Analysis of a Cohort of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis”. J Invest Dermatol 2013 Feb 7 [doi: 10.1038/jid.2012.510. Epub ahead of print].

  36. Shriner D, Schwartz R, Janniger C. “Impetigo”. Cutis 1994; 45: 30-32.

  37. Stevens DL, Bisno AL, Chambers HF, et al. “Practice guidelines for the diagnosis and management of skin and soft-tissue infections”. Clin Infect Dis 2005; 41: 1373.

  38. Edwards SK, “European Branch of the International Union against Sexually Transmitted Infection and the European Office of the World Health Organization. European guideline for the management of balanoposthitis”. Int J Std AIDS 2001; 12 (Suppl 3): 68.

  39. Stary A, Soeltz-Szoets J, Ziegler C, et al. “Comparison of the efficacy and safety of oral fluconazole and topical clotrimazole in patients with candida balanitis”. Genitourin Med 1996; 72: 98.

  40. Pappas PG, Kauffman CA, Andes D, et al. “Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America”. Clin Infect Dis 2009; 48: 503.

  41. Ross JD, Smith IW, Elton RA. “The epidemiology of herpes simplex types 1 and 2 infection of the genital tract in Edinburgh 1978-1991”. Genitourin Med 1993; 69: 381.

  42. Kimberlin DW, Rouse DJ. “Clinical practice. Genital herpes”. N Engl J Med 2004; 350: 1970.

  43. Benedetti JK, Zeh J, Corey L. “Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time”. Ann Intern Med 1999; 131: 14.

  44. Gupta R, Warren T, Wald A. “Genital herpes”. Lancet 2007; 370: 2127.

  45. Schomogyi M, Wald A, Corey L. “Herpes simplex virus-2 infection. An emerging disease?” Infect Dis Clin North Am 1998; 12: 47.

  46. Corey L, Fife KH, Benedetti JK, et al. “Intravenous acyclovir for the treatment of primary genital herpes”. Ann Intern Med 1983; 98: 914.

  47. http://www.cdc.gov/std/treatment/2010/default.htm Mattison HR, Reichman RC, Benedetti J, et al. “Double-blind, placebocontrolled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpes”. Am J Med 1988; 85:20.

  48. Cernik C, Gallina K, Brodell RT. “The treatment of herpes simplex infections: an evidence-based review”. Arch Intern Med 2008; 168: 1137.

  49. Corey L, Bodsworth N, Mindel A, et al. “An update on short-course episodic and prevention therapies for herpes genitalis”. Herpes 2007; 14 (Suppl 1): 5A.

  50. Dworkin RH, Johnson RW, Breuer J, et al. “Recommendations for the management of herpes zoster”. Clin Infect Dis 2007; 44(Suppl 1): S1.

  51. Rowbotham M, Harden N, Stacey B, et al. “Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial”. JAMA 1998; 280: 1837.

  52. Chen N, Ynag M, He L. “Corticosteroids for preventing postherpetic neuralgia”. Cochrane Database Syst Rev 2010 Dec; 8(12): CD005582.

  53. Gormley RH, Kovarik CL. “Human papillomavirus-related genital disease in the immunocompromised host (part I and II)”. J Am Acad Dermatol 2012; 66: 883.

  54. Von Krogh G, Lacey CJN, Gross G, et al. “European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts”. Sex Transm Infect 2000; 76: 162-168.

  55. Kwok CS, Holland R, Gibbs S. “Efficacy of topical treatments for cutaneous warts: a meta-analysis and pooled analysis of randomized controlled trials”. Br J Dermatol 2011; 165: 233-246.

  56. Hook EW 3rd, Marra CM. “Acquired syphilis in adults”. N Engl J Med 1992; 326:1060.

  57. Wong W, Chaw JK, Kent CK, Klausner JD. “Risk factors for early syphilis among gay and bisexual men seen in an STD clinic: San Francisco, 2002-2003”. Sex Transm Dis 2005; 32: 458.

  58. Blain AK, Elston DM. “Seborreic Keratosis”. http://emedicine.medscape. com/article/1059477-workup#a0722.

  59. Gill D, Dorevitch A, Marks R. “The prevalence of seborrheic keratoses in people aged 15 to 30 years: is the term senile keratosis redundant?” Arch Dermatol. Jun 2000; 136(6): 759-762.

  60. Provost N, Kopf AW, Rabinovitz HS, Oliviero MC, Toussaint S, Kamino HH. “Globulelike dermoscopic structures in pigmented seborrheic keratosis”. Arch Dermatol. Apr 1997; 133(4): 540-541.

  61. Schwartz RA, Elston DM. “Acrochordon”. http://emedicine.medscape.com/

  62. Lynch PJ. “Lichen simplex chronicus (atopic/neurodermatitis) of the anogenital región”. Dermatol Ther. 2004; 17(1): 8-19.

  63. Wikström A, Hedblad MA, Syrjän S. “Penile intraepithelial neoplasia: histopathological evaluation, HPV typing, clinical presentation and treatment”. JEADV 2012; 26: 325-330.

  64. Chaux A, Cubilla AL. “Advances in the pathology of penile carcinomas”. Human Pathology 2012; 43(6): 771-789.

  65. Chaux A, Velazquez EF, Barreto JE, Ayala E, Cubilla AL. “New pathologic entities in penile carcinomas: an update of the 2004 world health organization classification”. Semin Diagn Pathol. 2012 May; 29(2): 59-66.

  66. Rodríguez Pichardo A, “Lesiones precancerosas del pene y misceláneas”. Monografías de Dermatología, Patología genital masculina, no venérea. 2012; 25(2): 122-129.

  67. Seetharamu N, Ott PA, Pavlick AC. “Mucosal Melanomas: A Case- Based Review of the Literature”. Oncologist. 2010 July; 15(7): 772-781.

  68. Tran Janco JM, Markovic SN, Weaver AL, Cliby AW. “Vulvar and vaginal melanoma: Case series and review of current management options including neoadjuvant chemotherapy”. Gynecol Oncol. 2013; Feb 26 (en impresión).

  69. Sánchez R, Huang SF, Tamboli P, Prieto VG, Hester G, Pettaway A. “Melanoma of the penis, scrotum and male urethra: a 40-year single institution experience”. J Urol. 2005 Jun; 173(6): 1958.

  70. Bichakjian CK, Halpern AC, Johnson TM, Hood AF, Grichnik JM, Swetter SM, et al. “Guidelines of care for the management of primary cutaneous melanoma”. J Am Acad Dermatol 2011; 65: 1032-1047.




2020     |     www.medigraphic.com